These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12604703)

  • 1. Dose-dependent EEG effects of zolpidem provide evidence for GABA(A) receptor subtype selectivity in vivo.
    Visser SA; Wolters FL; van der Graaf PH; Peletier LA; Danhof M
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1251-7. PubMed ID: 12604703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroactive steroids differ in potency but not in intrinsic efficacy at the GABA(A) receptor in vivo.
    Visser SA; Gladdines WW; van der Graaf PH; Peletier LA; Danhof M
    J Pharmacol Exp Ther; 2002 Nov; 303(2):616-26. PubMed ID: 12388643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative kinetics and response to the benzodiazepine agonists triazolam and zolpidem: evaluation of sex-dependent differences.
    Greenblatt DJ; Harmatz JS; von Moltke LL; Wright CE; Durol AL; Harrel-Joseph LM; Shader RI
    J Pharmacol Exp Ther; 2000 May; 293(2):435-43. PubMed ID: 10773013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus effects of zolpidem in squirrel monkeys: role of GABA(A)/alpha1 receptors.
    Rowlett JK; Spealman RD; Lelas S; Cook JM; Yin W
    Psychopharmacology (Berl); 2003 Jan; 165(3):209-15. PubMed ID: 12420154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics, pharmacodynamics and the pharmacokinetic/ pharmacodynamic relationship of zolpidem in healthy subjects.
    de Haas SL; Schoemaker RC; van Gerven JM; Hoever P; Cohen AF; Dingemanse J
    J Psychopharmacol; 2010 Nov; 24(11):1619-29. PubMed ID: 19648220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo saturation binding of GABA-A receptor ligands to estimate receptor occupancy using liquid chromatography/tandem mass spectrometry.
    Hopkins SC; Brian Nofsinger J; Allen MS; Koch P; Varney MA
    Biopharm Drug Dispos; 2009 Jan; 30(1):9-20. PubMed ID: 19152227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Status epilepticus alters zolpidem sensitivity of [3H]flunitrazepam binding in the developing rat brain.
    Laurén HB; Lopez-Picon FR; Kukko-Lukjanov TK; Uusi-Oukari M; Holopainen IE
    Neuroscience; 2007 May; 146(2):802-11. PubMed ID: 17360122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gaboxadol -- a different hypnotic profile with no tolerance to sleep EEG and sedative effects after repeated daily dosing.
    Ebert B; Anderson NJ; Cremers TI; Rasmussen S; Vogel V; Fahey JM; Sánchez C
    Pharmacol Biochem Behav; 2008 Jul; 90(1):113-22. PubMed ID: 18304623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism-based pharmacokinetic-pharmacodynamic modeling of 5-HT1A receptor agonists: estimation of in vivo affinity and intrinsic efficacy on body temperature in rats.
    Zuideveld KP; Van der Graaf PH; Newgreen D; Thurlow R; Petty N; Jordan P; Peletier LA; Danhof M
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1012-20. PubMed ID: 14718609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential pharmacological properties of GABAA/benzodiazepine receptor complex in dorsal compared to ventral rat hippocampus.
    Sarantis K; Sotiriou E; Papatheodoropoulos C; Matsokis N; Angelatou F
    Neurochem Int; 2008 May; 52(6):1019-29. PubMed ID: 18069090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminative stimulus properties of GABAA receptor positive allosteric modulators TPA023, ocinaplon and NG2-73 in rats trained to discriminate chlordiazepoxide or zolpidem.
    Vinkers CH; Olivier B; Hanania T; Min W; Schreiber R; Hopkins SC; Campbell U; Paterson N
    Eur J Pharmacol; 2011 Oct; 668(1-2):190-3. PubMed ID: 21762686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling of alphak/gamma2 (k=1, 2, 3 and 5) interface of GABA A receptor and docking studies with zolpidem: implications for selectivity.
    Ci SQ; Ren TR; Ma CX; Su ZG
    J Mol Graph Model; 2007 Sep; 26(2):537-45. PubMed ID: 17451983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism-based pharmacokinetic/pharmacodynamic modeling of the electroencephalogram effects of GABAA receptor modulators: in vitro-in vivo correlations.
    Visser SA; Wolters FL; Gubbens-Stibbe JM; Tukker E; Van Der Graaf PH; Peletier LA; Danhof M
    J Pharmacol Exp Ther; 2003 Jan; 304(1):88-101. PubMed ID: 12490579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute zolpidem administration produces pharmacodynamic and receptor occupancy changes at similar doses.
    Fahey JM; Grassi JM; Reddi JM; Greenblatt DJ
    Pharmacol Biochem Behav; 2006 Jan; 83(1):21-7. PubMed ID: 16439007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic-pharmacodynamic modeling of the electroencephalographic effects of benzodiazepines. Correlation with receptor binding and anticonvulsant activity.
    Mandema JW; Sansom LN; Dios-Vièitez MC; Hollander-Jansen M; Danhof M
    J Pharmacol Exp Ther; 1991 Apr; 257(1):472-8. PubMed ID: 1850477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zolpidem modulates GABA(A) receptor function in subthalamic nucleus.
    Chen L; Xie JX; Fung KS; Yung WH
    Neurosci Res; 2007 May; 58(1):77-85. PubMed ID: 17337310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the novel subtype-selective GABAA receptor-positive allosteric modulator NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile] with diazepam, zolpidem, bretazenil, and gaboxadol in rat models of inflammatory and neuropathic pain.
    Munro G; Lopez-Garcia JA; Rivera-Arconada I; Erichsen HK; Nielsen EØ; Larsen JS; Ahring PK; Mirza NR
    J Pharmacol Exp Ther; 2008 Dec; 327(3):969-81. PubMed ID: 18791060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological and computational analysis of alpha-subunit preferential GABA(A) positive allosteric modulators on the rat septo-hippocampal activity.
    Ujfalussy B; Kiss T; Orbán G; Hoffmann WE; Erdi P; Hajós M
    Neuropharmacology; 2007 Mar; 52(3):733-43. PubMed ID: 17113111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sub-chronic administration of zolpidem affects modifications to rat sleep architecture.
    Renger JJ; Dunn SL; Motzel SL; Johnson C; Koblan KS
    Brain Res; 2004 Jun; 1010(1-2):45-54. PubMed ID: 15126116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors.
    Popik P; Kostakis E; Krawczyk M; Nowak G; Szewczyk B; Krieter P; Chen Z; Russek SJ; Gibbs TT; Farb DH; Skolnick P; Lippa AS; Basile AS
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1244-52. PubMed ID: 16971504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.